Vogliprl 0.2mg Tablet
Marketer
Pristine Pearl Pharma Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Vogliprl 0.2mg Tablet
Diabetil 0.2mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. Prescribed when dietary and other medication regimens prove insufficient, Diabetil 0.2mg should be ingested immediately prior to meals. Dosage frequency is determined individually by your physician to optimize glycemic control. Abrupt cessation is strongly discouraged; discontinuation should only occur under medical supervision, as it may trigger dangerously elevated blood glucose levels, potentially resulting in severe complications such as renal impairment or vision loss. This medication forms part of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include abdominal discomfort, including flatulence, decreased appetite, bowel irregularity, and nausea. Persistent or bothersome side effects warrant immediate medical attention. While Diabetil 0.2mg itself doesn't induce hypoglycemia, concomitant use with other antidiabetic agents, particularly insulin or sulfonylureas, elevates this risk. Hypoglycemic episodes require treatment with pure glucose; sucrose is ineffective. Prior to commencing treatment, inform your physician of any hepatic or renal conditions, or gastrointestinal inflammatory disorders (e.g., Crohn's disease, ulcerative colitis). Consult your doctor before using this medication during pregnancy or breastfeeding. Full disclosure of all current medications is crucial for safe use. Excessive alcohol consumption should be avoided as it can potentiate hypoglycemic episodes.
Uses of Vogliprl 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Vogliprl 0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vogliprl 0.2mg Tablet on an empty stomach.
Common Side effects of Vogliprl 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogliprl 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogliprl 0.2mg Tablet on an empty stomach.
How Vogliprl 0.2mg Tablet works:
Vogliprl 0.2mg tablets function as an antidiabetic agent by suppressing the activity of intestinal enzymes that digest complex carbohydrates. This action reduces postprandial spikes in blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogliprl 0.2mg Tablet and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vogliprl 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on limited available data in humans, the use of Vogliprl 0.2mg tablets during breastfeeding is considered likely safe, posing minimal apparent risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vogliprl 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Vogliprl 0.2mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Vogliprl 0.2mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vogliprl 0.2mg Tablet :
Omit any missed dose of Vogliprl 0.2mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogliprl 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently